AZUR PHARMA
Azur Pharma is a privately held pharmaceutical company dedicated to enhancing patients' lives by developing and marketing pharmaceutical products in specialist therapeutic areas. Azur Pharma's strategy is to identify, evaluate, selectively acquire and enhance the value of late-stage development and approved pharmaceutical products.
AZUR PHARMA
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2006-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.azurpharma.com
Total Employee:
101+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache Mobile Non Scaleable Content CPanel SSL CPanel Liquid Web CSC Global DNS CDNS Network
Similar Organizations
Amaxa Ukraine
Axama is a pharmaceutical company that provides medicine for oncology, hematology, neonatology, and non-prescription drugs.
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Taiho Oncology
Taiho Oncology is a pharmaceutical company that specializes in developing innovative cancer treatments.
Founder
Official Site Inspections
http://www.azurpharma.com
- Host name: 165.160.13.20
- IP address: 165.160.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Azur Pharma" on Search Engine
Jazz Pharmaceuticals - Wikipedia
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitterSee details»
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz ...
Jan 19, 2012 Jazz Pharmaceuticals has approximately 430 employees, including a commercial organization focused around four key areas: narcolepsy, severe chronic …See details»
Jazz Pharmaceuticals and Azur Pharma Agree to …
Sep 19, 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) and Azur Pharma Limited today announced that the companies have agreed to combine in an all-stock transaction that …See details»
Azur Pharma acquired by Jazz Pharmaceuticals
Acquired Organization: Azur Pharma Azur Pharma is a pharmaceutical company with commercial franchises in pain, psychiatry, women's health and orphan drugs.See details»
Azur Pharma Announces the Signing of a Definitive …
DUBLIN, March 11 /CNW/ - Azur Pharma Limited ("Azur") today announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, …See details»
Jazz Pharmaceuticals and Azur Pharma Agree to Combine to …
Sep 20, 2011 Azur Pharma is a privately-held, profitable specialty pharmaceutical company headquartered in Dublin, Ireland with US operations in Philadelphia. The …See details»
Azur Pharma Company Profile 2024: Valuation, …
1. Investments. 3. General Information. Description. Developer of biopharmaceutical products intended to focus on improving patients' lives by identifying, developing, and commercializing meaningful products …See details»
Azur to merge with US pharma firm in $500m deal - The …
Sep 21, 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan, has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that …See details»
Azur Pharma agrees to all-stock merger with Jazz …
Sep 20, 2011 Azur Pharma agrees to all-stock merger with Jazz Pharma to create firm with $474 million revenues. 20-09-2011 Print. USA-based drugmaker Jazz …See details»
Azur Pharma - Updates, News, Events, Signals & Triggers
Sep 19, 2011 Azur Pharma is a pharmaceutical company with commercial franchises in pain, psychiatry, women's health and orphan drugs.See details»
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz ...
Jan 18, 2012 Jazz Pharmaceuticals has approximately 430 employees, including a commercial organization focused around four key areas: narcolepsy, severe chronic …See details»
AixThera – Impactful Therapeutics
Our Mission. AixThera was formed to invest in the development of new therapeutics with the potential to positively impact patient lives. Our Team. Seamus Mulligan. David …See details»
Jazz Pharmaceuticals and Azur Pharma Agree to Combine to …
Sep 19, 2011 Azur Pharma is a privately-held, profitable specialty pharmaceutical company headquartered in Dublin, Ireland with US operations in Philadelphia. The …See details»
AzurRx BioPharma Announces Acquisition of First Wave Bio and …
Sep 13, 2021 First Wave Bio is a clinical-stage biotechnology company specializing in the development of novel, gut-targeted, small molecule therapies for auto-immune …See details»
Azur Pharma - Contacts, Employees, Board Members, Advisors …
Azur Pharma is a pharmaceutical company with commercial franchises in pain, psychiatry, women's health and orphan drugs.See details»
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz ...
Jan 18, 2012 Jazz Pharmaceuticals has approximately 430 employees, including a commercial organization focused around four key areas: narcolepsy, severe chronic …See details»
AzurRx BioPharma Announces $3.0 Million Bought Deal Offering …
BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical …See details»
Pharmaceutical Consulting & Services | Azzur Group
With over 30 years of experience, Azzur’s pharmaceutical consulting, validation, IT, and laboratory services enable.See details»
Our Mission - AzurBio Pharma
By forging strategic partnerships with international pharmaceutical and biotech firms, we engage in joint ventures and introduce disruptive, customized, or turnkey solutions …See details»
AzurBio Pharma: Innovation to European patients
We believe in disruption by partnering with biopharmaceutical companies in the field of rare or serious diseases, to introduce peace of mind solutions to bring innovative drugs …See details»